GH1 and ovarian hyperstimulation syndrome: The studies investigating Letrozole, Cetrotide, growth hormone (GH) supplementation, and the gonadotropin hormone-releasing hormone (GnRH) antagonist showed improvements in fertility outcomes, including pregnancy rates, ovarian hyperstimulation syndrome (OHSS), and granulosa cell survival [25-28].